What does this research mean for the field?

Cardiotrophin-1 (CT-1) protects the adult heart from ischaemia/reperfusion injury when administered either prior to ischaemia or at the time of reperfusion, an effect mediated by the p42/p44 MAPK pathway. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.NEUTRAL.

March 1, 2002Cardiovascular ResearchOpen Access

Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion

View Full Paper

Ask AI

Bookmark

Why the study?

Does Cardiotrophin-1 (CT-1) reduce ischemic damage in adult rat cardiocytes and intact hearts exposed to ischemia/reperfusion?

Population

Cultured adult rat cardiocytes and rat intact heart models exposed to hypoxia/ischemia followed by…

Comparison

Cardiotrophin-1 administered either prior to… vs Control (no CT-1)

Design

Preclinical

Authors

ZLZhihong LiaoSouth China Agricultural University

Discussion

Member takes

Implication

Hypothesis-generating in adult rat ischemia/reperfusion; extends neonatal protection but leaves open clinical translation.

Structured PICO

Does Cardiotrophin-1 (CT-1) reduce ischemic damage in adult rat cardiocytes and intact hearts exposed to ischemia/reperfusion?

Population

Cultured adult rat cardiocytes and rat intact heart models exposed to hypoxia/ischemia followed by reoxygenation/reperfusion

Intervention

Cardiotrophin-1 (CT-1) administered either prior to hypoxia/ischemia or at reoxygenation/reperfusion

Comparator

Control (no CT-1)

Outcome

Ischemic damage assessed by infarct size to area at risk ratio (ex vivo) and cell death via TUNEL assay (in vitro)surrogate

Cardiotrophin-1 (CT-1) demonstrates protective effects against ischemia/reperfusion injury in adult rat hearts and cardiocytes, mediated via the p42/p44 MAPK pathway.

Cite This Study

Zhihong Liao (2002) studied this question.

synapsesocial.com/papers/6a1a2cc6db849bfdc47fc9bd https://doi.org/10.1016/s0008-6363(01)00531-4

View Full Paper

Ask AI

Bookmark